The Nephrostomy Devices Market is expected to grow at a CAGR of 4.5% to reach USD 75.4 million by 2028. The market for nephrostomy devices is witnessing significant growth due to the increasing prevalence of kidney stones and the development of less invasive procedures, such as mini PCNL. Traditional PCNL, while effective in treating kidney stones, is often indicated as second-line therapy due to its invasiveness and associated complications, including hemorrhage, greater postoperative pain, and longer hospital stays. In response, mini PCNL or mini percutaneous nephrolithotomy was developed, featuring smaller incisions and instruments to minimize procedural morbidity and complications. Notably, KARL STORZ SE and Co. KG has introduced the MIP?M device, a miniaturized version of PCNL, which can manage kidney stones up to 30 mm in diameter in any renal calyx or the renal pelvis, thereby reducing hospital stays and improving patient outcomes.
North America dominates the regional market because of The Nephrostomy Devices Market refers to the industry segment that produces and supplies medical devices used for drainage of urine from the kidneys, bypassing obstructed or non-functioning ureters. These devices are essential for managing conditions such as kidney stones, hydronephrosis, and other renal disorders. Market growth is driven by an aging population, increasing prevalence of renal diseases, and technological advancements in nephrostomy devices. Key players in this market include B. Braun Melsungen AG, Fresenius Medical Care AG & Co. KG, and Becton, Dickinson and Company.
There are various factors that drive the Nephrostomy Devices Market market which are as following: Kidney stones, crystalline concentrations of minerals, represent a substantial health issue with rising clinical and economic implications for millions worldwide. Approximately 120,000 individuals per million population globally experience kidney stones at some point in their lives, affecting individuals of all ages, sexes, and races. Prevalence rates have escalated in both developed and developing countries, with a higher lifetime risk in the Middle East and Western regions compared to Africa and Asia. The condition, more common among men under 50 years old, necessitates the continuous development and advancement of nephrostomy devices for effective treatment and management.
Be the first one to get the industry updates. Request for a sample report
Nephrostomy Devices Market Segmentation
The market witnesses several challenges, which are as follows Nephrostomy devices, while essential for draining urine from the kidneys, carry potential complications. These include hemorrhage, tube dislodgement, tube blockage, and leakage. Additional risks involve infection-related issues such as fever, damage to adjacent structures, vascular injury, and catheter-associated urinary tract infections (CAUTI). Septicemia, septic shock, and allergic reactions are also possible. Diabetic patients undergoing nephrostomy procedures are at increased risk for postoperative complications. Improper reprocessing and reuse of devices can lead to infections. The Centers for Disease Control and Prevention (CDC) reports that approximately 75% of hospital-acquired urinary tract infections are linked to urinary catheters. Adherence to proper sterilization protocols and patient monitoring is crucial to mitigate these risks.
Stay ahead of your competitors. Download the Free PDF report
Some of the key companies that have been profiled in the report include:
In accordance with Technavio's market analysis, the nephrostomy devices market is a significant segment within the expansive global healthcare equipment industry. This sector encompasses entities involved in the research and development (R&D) of various product categories, such as capital equipment, instruments, implants, accessories, and consumables. The global healthcare equipment market size is determined by the consolidated revenue generated by manufacturers of diagnostic equipment and devices utilized across diverse therapy areas. The healthcare equipment sector is segmented into Devices, which incorporates advanced, differentiated, and clinically tested data-driven devices, including nephrostomy devices. - The Nephrostomy Devices Market is experiencing significant growth, fueled by the Increasing incidence of kidney stone disease. Businesses are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
The Nephrostomy Devices Market has witnessed significant growth due to the increasing prevalence of urolithiasis, chronic kidney diseases, tumors, and urinary tract obstruction. According to the National Kidney Foundation, over 13 million Americans have chronic kidney disease, and urolithiasis affects around 11% of the population. Urolithiasis treatment requires frequent patient visits to clinics and hospitals for diagnosis and treatment, leading to increased healthcare spending. Major players in the Nephrostomy Devices Market include Cook Medical and Cardinal Health. These medical device companies manufacture and supply sheath dilators, drainage tubes, guidewires, and nephrostomy catheters for the treatment of urolithiasis, hydronephrosis, and post-operative infections. The market is also driven by the growing trend of minimally invasive surgical procedures and the increasing number of ambulatory surgical centers. Moreover, medical tourism is also fueling the growth of the Nephrostomy Devices Market, as patients travel to countries with lower healthcare costs for treatment. The market is further expected to grow due to the rising incidence of chronic ailments such as prostate, ovarian, and bladder cancer. However, the risk of post-operative infections remains a significant challenge for the market. In conclusion, the Nephrostomy Devices Market is poised for growth due to the increasing prevalence of kidney stone disorder, chronic kidney diseases, and tumors. The market is driven by major players such as Cook Medical and Cardinal Health, and the trend towards minimally invasive surgical procedures and medical tourism is also expected to boost growth. However, the risk of post-operative infections remains a significant challenge for the market.
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
